CD40 Ligand Uses, Dosage, Side Effects and more

CD40 Ligand is under investigation in clinical trial NCT00053391 (Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma).

Trade Name CD40 Ligand
Generic Recombinant CD40-ligand
Recombinant CD40-ligand Other Names CD40 ligand, Recombinant CD40-ligand
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph


*** Taking medicines without doctor's advice can cause long-term problems.
Share